Majumdar G, Payne R W
Clin Lab Haematol. 1985;7(2):125-31. doi: 10.1111/j.1365-2257.1985.tb00016.x.
Three hundred and eighty-four patients were studied for up to 1 year while on continuous oral anticoagulant therapy and the quality of control of therapy was assessed. Two hundred and thirty-five patients were on continuous therapy throughout the year (long-term group), 73 were treated for a period between 3 and 12 months (intermediate group) and 76 were treated for less than 3 months (short-term group). The therapeutic objective was to achieve and maintain British Ratio (BR) between 2.0 and 4.0. Nineteen percent of the results in the long-term group, 26.6% in the intermediate group and 41.1% in the short-term group fell outside this range. Among the long-term group only 25.1% and in the intermediate group 12.3% had all their results within the control range. It is concluded that the quality of therapeutic control of oral anticoagulant therapy needs to be improved.
对384例接受持续口服抗凝治疗长达1年的患者进行了研究,并对治疗的控制质量进行了评估。235例患者全年接受持续治疗(长期组),73例接受3至12个月的治疗(中期组),76例接受少于3个月的治疗(短期组)。治疗目标是使英国比值(BR)达到并维持在2.0至4.0之间。长期组中19%的结果、中期组中26.6%的结果以及短期组中41.1%的结果超出了该范围。在长期组中,只有25.1%的结果以及中期组中12.3%的结果全部在控制范围内。得出的结论是,口服抗凝治疗的治疗控制质量需要提高。